Skip to main content
Clinical Trials/CTRI/2021/06/034421
CTRI/2021/06/034421Recruiting未知

A Comparative Study of Oral Cyclophosphamide vs Mycophenolate Mofetil in Children with Frequent Relapsing Steroid Dependent Nephrotic Syndrome

GURDEEP SINGH DHOORIA0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Children with Frequent Relapsing Steroid Dependent Nephrotic Syndrome

Exclusion Criteria

  • 1. Congenital Nephrotic Syndrome
  • 2. Steroid Resistant Nephrotic Syndrome
  • 3. Patients with an estimated glomerular filtration rate ( <60 ml/min
  • per 1.73 m2
  • 4. Known secondary causes including systemic lupus, Henoch
  • Schonlein purpura, IgA nephropathy or chronic infection (tuberculosis, HIV, hepatitis B or C.
  • 5. Prior therapy with MMF, cyclosporine, tacrolimus, or cyclophosphamide in the past 6 months.

Investigators

Sponsor
GURDEEP SINGH DHOORIA

Similar Trials